Prostate cancer is the most commonly diagnosed cancer in American men and the third leading cause of cancer-related deaths. However, the decision whether to pursue early detection of prostate cancer is complex; because not all men with prostate cancer will die of this disease, treatment is not necessary for some. These guidelines are intended to help men and clinicians choose a program for early detection of prostate cancer and make decisions about the need for prostate biopsy. For the most recent version of the guidelines, please visit NCCN.org
No takes yet. Share an insight, caveat, or question.
A 2007 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: